glycyl-arginyl-glycyl-aspartyl-seryl-proline has been researched along with Chronic Kidney Failure in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dobos, G; Gawaz, MP; Gurland, HJ; Mujais, SK; Schollmeyer, P; Späth, M | 1 |
1 other study(ies) available for glycyl-arginyl-glycyl-aspartyl-seryl-proline and Chronic Kidney Failure
Article | Year |
---|---|
Impaired function of platelet membrane glycoprotein IIb-IIIa in end-stage renal disease.
Topics: Adenosine Diphosphate; Amino Acid Sequence; Antibodies, Monoclonal; Epitopes; Erythropoietin; Female; Fibrinogen; Flow Cytometry; Hemorrhagic Disorders; Humans; Kidney Failure, Chronic; Male; Molecular Sequence Data; Oligopeptides; Platelet Aggregation; Platelet Membrane Glycoproteins; Protein Binding; Protein Conformation; Recombinant Proteins; Renal Dialysis; Tetradecanoylphorbol Acetate | 1994 |